chr12-95983909-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_002108.4(HAL):c.1287+2T>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,467,544 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/2 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance,association (★★).
Frequency
Consequence
NM_002108.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000200 AC: 50AN: 250290Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 135270
GnomAD4 exome AF: 0.000255 AC: 335AN: 1315306Hom.: 0 Cov.: 22 AF XY: 0.000242 AC XY: 160AN XY: 662202
GnomAD4 genome AF: 0.000151 AC: 23AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74376
ClinVar
Submissions by phenotype
Histidinemia Uncertain:1
The HAL c.1287+2T>C variant occurs in a canonical splice site (donor) site and is therefore predicted to disrupt or distort the normal gene product. This variant has been reported in one study in which it is found in a heterozygous state in one individual with raised histidine levels from the Atherosclerosis Risk in Communities (ARIC) study (Yu et al. 2015). Control data are unavailable for the c.1287+2T>C variant, which has been reported at a frequency of 0.00070 in the European American population of the Exome Sequencing Project. The evidence for this variant is limited but in combination with the the potential impact of splice donor variants, the c.1287+2T>C variant is classified as a variant of unknown significance but suspicious for pathogenicity for histidinemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
Increased histidine Other:1
Three heterozygous loss-of-function variants in HAL were found in 24/1152 African American individuals, in association with elevated serum histidine levels. Histidine level is a potential predictor of cardiovascular risk. Thus, loss-of-function variants in HAL may modify cardiovascular risk. Findings were replicated in a European American cohort. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at